CA1101840A - Traduction non-disponible - Google Patents

Traduction non-disponible

Info

Publication number
CA1101840A
CA1101840A CA318,788A CA318788A CA1101840A CA 1101840 A CA1101840 A CA 1101840A CA 318788 A CA318788 A CA 318788A CA 1101840 A CA1101840 A CA 1101840A
Authority
CA
Canada
Prior art keywords
propylene glycol
alpha
cephem
amino
acetamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA318,788A
Other languages
English (en)
Inventor
Masataka Fukumura
Hisao Tobiki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Application granted granted Critical
Publication of CA1101840A publication Critical patent/CA1101840A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Cephalosporin Compounds (AREA)
CA318,788A 1977-12-30 1978-12-28 Traduction non-disponible Expired CA1101840A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP160339/77 1977-12-30
JP16033977A JPS5495589A (en) 1977-12-30 1977-12-30 Production of cephalosporin derivative

Publications (1)

Publication Number Publication Date
CA1101840A true CA1101840A (fr) 1981-05-26

Family

ID=15712832

Family Applications (1)

Application Number Title Priority Date Filing Date
CA318,788A Expired CA1101840A (fr) 1977-12-30 1978-12-28 Traduction non-disponible

Country Status (5)

Country Link
JP (1) JPS5495589A (fr)
CA (1) CA1101840A (fr)
ES (1) ES476196A1 (fr)
IT (1) IT1109398B (fr)
MX (1) MX5389E (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696183B2 (en) 2006-12-12 2010-04-13 Apotex Pharmachem Inc. Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
US7834195B2 (en) 2007-01-24 2010-11-16 Apotex Pharmachem Inc. Atorvastatin calcium propylene glycol solvates
EP2339328A3 (fr) * 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques cocrystallisees de celecoxib
US8492423B2 (en) 2002-12-30 2013-07-23 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
CN103641845B (zh) * 2013-12-11 2015-08-19 中国医药集团总公司四川抗菌素工业研究所 一种丙二醇头孢曲嗪的制备方法
EP2139494B1 (fr) 2007-03-22 2020-03-11 AstraZeneca AB Préparations pharmaceutiques contenant de l'hydrate de propylèneglycol de dapagliflozine
US10633344B2 (en) 2002-03-01 2020-04-28 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11512730A (ja) * 1995-09-29 1999-11-02 ギスト ブロカデス ベスローテン フェンノートシャップ ペニシリングリコレート
WO2004060347A2 (fr) * 2002-09-03 2004-07-22 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques de solvates de propylene glycol
IL165383A0 (en) * 2002-06-21 2006-01-15 Transform Pharmaceuticals Inc Pharmaceutical compositions with improved dissolution

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10633344B2 (en) 2002-03-01 2020-04-28 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
EP2339328A3 (fr) * 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques cocrystallisees de celecoxib
US8492423B2 (en) 2002-12-30 2013-07-23 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7696183B2 (en) 2006-12-12 2010-04-13 Apotex Pharmachem Inc. Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
US7834195B2 (en) 2007-01-24 2010-11-16 Apotex Pharmachem Inc. Atorvastatin calcium propylene glycol solvates
US8188300B2 (en) 2007-01-24 2012-05-29 Apotex Pharmachem Inc. Atorvastatin calcium propylene glycol solvates
EP2139494B1 (fr) 2007-03-22 2020-03-11 AstraZeneca AB Préparations pharmaceutiques contenant de l'hydrate de propylèneglycol de dapagliflozine
EP2508188B1 (fr) 2007-03-22 2023-05-10 AstraZeneca AB Formulations pharmaceutiques contenant un hydrate de propylèneglycol dapagliflozine
CN103641845B (zh) * 2013-12-11 2015-08-19 中国医药集团总公司四川抗菌素工业研究所 一种丙二醇头孢曲嗪的制备方法

Also Published As

Publication number Publication date
IT7852465A0 (it) 1978-12-28
JPS5495589A (en) 1979-07-28
MX5389E (es) 1983-07-07
IT1109398B (it) 1985-12-16
ES476196A1 (es) 1979-11-16

Similar Documents

Publication Publication Date Title
KR100442717B1 (ko) 세프디니르의 결정성 아민 염
KR840001776B1 (ko) 세프타지딤 펜타하이드레이트의 제조방법
KR970008126B1 (ko) 결정성 7-[2-(2-아미노티아졸-4-일)-2-히드록시이미노아세트아미도]-3-비닐-3-세펨-4-카복실산[신 이성체]
CA1101840A (fr) Traduction non-disponible
CA1051799A (fr) Agents antibacteriens
EP0030294B1 (fr) Procédé de préparation de dérivés de céphalosporine; intermédiaires et leur préparation
EP0005830B1 (fr) Dérivés de céphalosporine, leur préparation et les compositions pharmaceutiques correspondants
IE56488B1 (en) Crystalline cephem-acid addition salts and process for their preparation
DE2736471C2 (fr)
SU867311A3 (ru) Способ получени D-7-[ @ -(4-окси-6-метилникотинамидо)- @ -(4-оксифенил)ацетамидо-3-(1-МЕТИЛТЕТРАЗОЛ-5-ИЛТИОМЕТИЛ)-3-ЦЕФЕМ-4-КАРБОНОВОЙ КИСЛОТЫ
EP0157538A2 (fr) Sels cristallins de ceftazidime
KR100532898B1 (ko) 플루다라빈 포스페이트의 제조를 위한 정제 방법
EP1273586A1 (fr) Cristal de penicilline et procede de production correspondant
JP2002338578A (ja) β−ラクタム化合物の水和物結晶
HU202536B (en) Process for producing 7-imidazolidinone derivative of cefem derivative antibiotics
KR920003902B1 (ko) 페니실린 유도체의 수화물 및 그 제조방법
US4168376A (en) Process for crystalline sodium cefamandole
CA1282407C (fr) Sel d'addition cristallin cephem-acide carboxylique
EP0039967B1 (fr) Soluté d'amoxycilline, procédé de préparation et procédé pour la préparation de formes injectables de ce soluté
JPH05178861A (ja) ジアステレオマー的に純粋な１−（２，２−ジメチルプロピオニルオキシ）−エチル３−セフェム−４−カルボキシレートの結晶性の酸付加塩
US6388098B1 (en) Process for preparing ascorbic acid-2-monophosphate salt
US4237280A (en) Intermediate for cephalosporin type compound
KR880000691B1 (ko) 세팔렉신의 수용성 유도체의 제조 방법
US3687947A (en) Method for recovery of cephaloridine
DE3006916A1 (de) Ungesaettigte 3-heterocyclische-thiomethyl-7 alpha -methoxy-7 beta -acylamido-3-cephem-4-carbonsaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische und veterinaermedizinische zubereitungen

Legal Events

Date Code Title Description
MKEX Expiry